VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Vanda Pharmaceuticals Inc. (VNDA) Total Return Calculator with Dividends Reinvested

Vanda Pharmaceuticals Inc.

Popular:

The total return for Vanda Pharmaceuticals Inc. (VNDA) stock is +70.25% over the past 12 months. So far it's down 9.82% this year. The 5-year total return is -57.51%, meaning $10,000 invested in VNDA stock 5 years ago would be worth $4,249 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in VNDA 1 year ago, it would be worth $16,986 today — you'd have gained $6,986.

With Dividends Reinvested$16,986+69.86%

Price Only (No DRIP)$16,986+69.86%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in VNDA

1Y$17,025+$7,025 (+70.3%)70.3% CAGR

3Y$10,736+$736 (+7.4%)2.4% CAGR

5Y$4,249-$5,751 (-57.5%)-15.7% CAGR

10Y$8,641-$1,359 (-13.6%)-1.4% CAGR

15Y$9,612-$388 (-3.9%)-0.3% CAGR

20Y$7,890-$2,110 (-21.1%)-1.2% CAGR

30Y$7,686-$2,314 (-23.1%)-0.9% CAGR

Vanda Pharmaceuticals Inc. did not pay dividends during this period. Total return = price return.

Loading VNDA total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-9.82%	—	-9.82%	—	$9,018
1Y	+70.25%	70.25%	+70.25%	—	$17,025
3Y	+7.36%	2.40%	+7.36%	—	$10,736
5Y	-57.51%	-15.73%	-57.51%	—	$4,249
10Y	-13.59%	-1.45%	-13.59%	—	$8,641
15Y	-3.88%	-0.26%	-3.88%	—	$9,612
20Y	-21.10%	-1.18%	-21.10%	—	$7,890
30Y	-23.14%	-0.87%	-23.14%	—	$7,686

Risk & Highlights

Best Year+1945.45%2009

Worst Year-92.31%2008

Max Drawdown-34.69%2025-12-31 → 2026-02-20 · Recovered 2026-02-27

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+8.00%	+8.00%	—	+0.41%	+7.6pp
2025	+82.99%	+82.99%	—	+16.64%	+66.3pp
2024	+5.97%	+5.97%	—	+24.00%	-18.0pp
2023	-43.13%	-43.13%	—	+24.81%	-67.9pp
2022	-55.35%	-55.35%	—	-19.95%	-35.4pp

VNDA outperformed the S&P 500 by 38.93pp over the past year (+70.25% vs +31.32%).

Loading summary...

VNDA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
VNDAVanda Pharmaceuticals Inc.	$440M	+6.7%	-9.8%	+70.3%	—	+7.4%	-57.5%	-13.6%
SUPNSupernus Pharmaceuticals, Inc.	$3.0B	+1.8%	+4.0%	+58.6%	—	+39.8%	+75.7%	+240.3%
PTCTPTC Therapeutics, Inc.	$5.5B	-3.3%	-13.2%	+84.1%	—	+19.9%	+65.2%	+839.5%
ACADACADIA Pharmaceuticals Inc.	$3.7B	-3.8%	-17.9%	+47.7%	—	-0.3%	+2.5%	-22.3%
INVAInnoviva, Inc.	$1.9B	-2.2%	+13.3%	+20.4%	—	+92.8%	+95.5%	+90.5%
PCRXPacira BioSciences, Inc.	$932M	+6.4%	-3.1%	-5.8%	—	-43.9%	-62.5%	-50.0%
HALOHalozyme Therapeutics, Inc.	$7.8B	+5.2%	-5.6%	+11.7%	—	+119.1%	+39.1%	+598.4%
JAZZJazz Pharmaceuticals plc	$14.3B	+22.3%	+32.0%	+105.6%	—	+64.8%	+32.2%	+58.3%
AVPTAvePoint, Inc.	$2.2B	+2.4%	-22.3%	-39.5%	—	+131.8%	+1.1%	+5.0%
AXSMAxsome Therapeutics, Inc.	$11.5B	+31.2%	+24.6%	+98.5%	—	+186.4%	+295.0%	+1858.0%
INTRInter & Co, Inc.	$2.5B	-0.9%	-5.9%	+18.2%	+1.7pp	+328.9%	+131.7%	+131.7%

Compare:VNDA vs SUPN VNDA vs PTCT VNDA vs ACAD VNDA vs SUPN vs PTCT

About VNDA Dividend Returns

Vanda Pharmaceuticals Inc. (VNDA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of VNDA over the past year?

Vanda Pharmaceuticals Inc. (VNDA) delivered a return of 70.25% over the past year. Since VNDA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in VNDA be worth today?

A $10,000 investment in Vanda Pharmaceuticals Inc. one year ago would be worth $17,025 today, representing a gain of $7,025.

Q3Does VNDA pay dividends?

Vanda Pharmaceuticals Inc. (VNDA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For VNDA, the total return equals the price-only return.

Q4Did VNDA beat the S&P 500?

Yes, Vanda Pharmaceuticals Inc. (VNDA) outperformed the S&P 500 by 38.93 percentage points over the past year. VNDA delivered a total return of 70.25%, compared to the S&P 500's 31.32%. This 38.93pp alpha means investors in VNDA earned more than a passive S&P 500 index fund.

Q5What is VNDA's worst drawdown?

Vanda Pharmaceuticals Inc. (VNDA) experienced a maximum drawdown of -34.69% over the past year, declining from its peak on 2025-12-31 to its trough on 2026-02-20. The stock recovered to its prior peak by 2026-02-27. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is VNDA's long-term total return over 10, 20, or 30 years?

Here are Vanda Pharmaceuticals Inc. (VNDA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -13.6% (-1.4% CAGR) — $10,000 would have grown to $8,641. Over 20 years: -21.1% total return (-1.2% CAGR) — $10,000 → $7,890. Over 30 years: -23.1% total return (-0.9% CAGR) — $10,000 → $7,686. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was VNDA's best and worst year?

Vanda Pharmaceuticals Inc.'s best calendar year was 2009 with a total return of 1945.5%. Its worst year was 2008 with a total return of -92.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 2037.8 percentage points.